SHALINI PAPPACHAN: Open Payments
NPI 1598217317 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 9 payments from 7 companies in 2025. Trend: 2023 $899 · 2024 $583 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $185 |
| Stemline Therapeutics Inc. | 1 | $111 |
| SpringWorks Therapeutics, Inc. | 1 | $100 |
| Gilead Sciences, Inc. | 1 | $89 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $37 |
| BridgeBio Pharma, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: REPATHA, Orserdu, OGSIVEO, Trodelvy, LifeVest, Attruby, LEQVIO.
Industry payments across TX — which companies pay providers there.
